1. Ritz E, Rychlik I, LocatelliF,etal.End-stage renal failure in type 2 diabetes: amedical catastrophe of worldwide dimensions.Am J Kidney Dis1999; 34: 795 -808.
2. Stocker R, Yamamoto Y, McDonagh AF, et al.: Bilirubin is an antioxidant of possible physiological importance. 235:1043-1046, 198.
3.Stocker R: Induction of haemoxygenase as a defence against oxidative stress. Free Radic Res Commun9:101-112, 1990.
4.Abraham NG, Kappas A: Hemeoxygenase and the cardiovascular-renal system. Free RadicBiol Med39:1-25, 2005.
5.Morita T: Hemeoxygenase and atherosclerosis. ArteriosclerThrombVasc Biol25:1786-1795, 2005.
6. Fukui M, Tanaka M, Shiraishi E, Harusato I, Hosoda H, Asano M, Hasegawa G, Nakamura N: Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. Kidney Int. 2008, 74: 1197-1201
7. KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;49.
8. Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107: 1058-107.
9. Fukui M, Tanaka M, Shiraishi E, Harusato I, Hosoda H, Asano M, Hasegawa G, Nakamura N. Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. Kidney Int. 2008;74:1197–1201. doi:
11. Targher G, Zoppini G, Cesare Guidi G, Lippi G. Relationship between serum bilirubin and kidney function in non-diabetic and diabetic individuals. Kidney Int. 2009;75:863